Description
This program is available until December 31, 2020.
Program Chair: Lisa Button
Speakers: Pamela Johnson; Lisa Button; Chelsea Conn, MLS (ASCP)
Intended Audience: Donor Recruiter, Manager, Medical Director, Nurse, Perfusionist, Physician, Research Scientist, Residents/Fellow, Student (MD, MT, SBB), Supervisor, Technologist, Transfusion Safety Officer
Teaching Level: Intermediate
Learning Objectives:
- Discover novel sources of data and determine how to identify data worth using
- Evaluate available tools and choose ones that will make a Quality/Process Improvement successful
- Discuss data driven project improvement case studies and apply lessons learned to your own processes
Description: This session will enable attendees to identify worthwhile data (data worth collecting) by helping them discover where data can come from (LIS, Medical Record, Institutional reports, novel ideas), and the importance of validating the integrity of the data being downloaded. It is critical to understand the way the software or data source works (e.g. how is the data imported; understand how the data is displayed and what does it mean, know the fields of your software to better understand report outputs). The presentation will provide the audience with helpful strategies for identifying important/useful information and describe how to sort it from data that might not be useful at the current time. The presentation will identify how to use the data you’re collecting to drive Quality/Process Improvement by discussing tools for data collection and display.
Finally, the presentation will provide examples of data driven projects from a large teaching institution with discussion of real world application of gathering data, how to sort it, display it, get buy in from stakeholders, and use it to drive change. Examples will cover a range of topics from Perioperative practice improvement, Transfusion Service practice changes, financial considerations involved in providing patient care, staffing to workload as well as a multidisciplinary approach to implementing a Platelet Rich Plasma (PRP) program.
Speaker(s):
